Visikol – Contract Research Services – Home2022-06-08T10:41:32-05:00


NASH 3D Cell Culture Assays

Our expertise in 3D cell culture models and quantitative evaluation allows for an unparalleled evaluation of compounds which ameliorate the NASH continuum.

Read More

HUREL Primary Hepatocyte Micro Livers

The HUREL portfolio of primary hepatocyte models and services are now part of Visikol which includes over ten animal species and multiple new services.

Read More

Tissue Analysis for Immuno-oncology

Automated analysis of the number, distribution, and infiltration of immune cell sub-types within tumor tissue specimens.

Read More

Highly Multiplexed Slide Imaging

We provide our Clients with the ability to move beyond traditional slide labeling and imaging such that they can achieve 10+ labels on a single slide, all delivered in an easy-to-read report.

Read More

Ready to Accelerate Your Research?

Request a Quote

We will get back to you within an hour if request is submitted during normal business hours

“I am very impressed with the thoroughness of the analysis. I hope to steer more data your way soon. Again, thank you for undertaking this at a small cost. It is much appreciated.”

Marie M., Palatin Technologies

“Thanks for getting this back so quickly, and for the thoroughness of the design and report. We look forward to working with you again!”

George M.

“A pleasure to work with. Concise and detailed report for our 3D cell assay. We’ll have more projects your way soon!”

William Holden

“Extremely impressive work, thanks for getting this back to us so quickly. I really appreciate the detailed analysis.”

Ray C.

Featured Posts

An In-Depth Look at PCLS Models

June 29th, 2022|

Non-alcoholic fatty liver disease (NAFLD) is the most chronic form of liver disease, which affects about quarter of the population in the US. Nearly half of the patients suffering from NAFLD can progress to [...]

Visikol’s Development of a BBB Model

June 22nd, 2022|

As drug discovery continues to progress and adapt to modern day scientific challenges, the scope of pharmaceutical development becomes increasingly more comprehensive. Like Visikol, many research organizations are making the shift from animal models [...]

Previous Posts >>

Our Clients Include

This website uses cookies to enhance the user experience. Ok